Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17300231rdf:typepubmed:Citationlld:pubmed
pubmed-article:17300231lifeskim:mentionsumls-concept:C0025202lld:lifeskim
pubmed-article:17300231lifeskim:mentionsumls-concept:C0253023lld:lifeskim
pubmed-article:17300231lifeskim:mentionsumls-concept:C0245662lld:lifeskim
pubmed-article:17300231lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:17300231lifeskim:mentionsumls-concept:C0525037lld:lifeskim
pubmed-article:17300231lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:17300231lifeskim:mentionsumls-concept:C1539477lld:lifeskim
pubmed-article:17300231lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:17300231lifeskim:mentionsumls-concept:C0062186lld:lifeskim
pubmed-article:17300231lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:17300231pubmed:issue3lld:pubmed
pubmed-article:17300231pubmed:dateCreated2007-2-15lld:pubmed
pubmed-article:17300231pubmed:abstractTextThe incidence of malignant melanoma is increasing worldwide and patients are being diagnosed earlier with thinner primary lesions. Most patients with very thin melanoma (Breslow thickness < 0.76 mm) are cured by surgery but 2-18% relapse locally or with distant metastases.lld:pubmed
pubmed-article:17300231pubmed:languageenglld:pubmed
pubmed-article:17300231pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17300231pubmed:citationSubsetIMlld:pubmed
pubmed-article:17300231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17300231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17300231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17300231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17300231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17300231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17300231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17300231pubmed:statusMEDLINElld:pubmed
pubmed-article:17300231pubmed:monthMarlld:pubmed
pubmed-article:17300231pubmed:issn0007-0963lld:pubmed
pubmed-article:17300231pubmed:authorpubmed-author:MacKieRRlld:pubmed
pubmed-article:17300231pubmed:authorpubmed-author:FisherCClld:pubmed
pubmed-article:17300231pubmed:authorpubmed-author:GoreM EMElld:pubmed
pubmed-article:17300231pubmed:authorpubmed-author:FrancisNNlld:pubmed
pubmed-article:17300231pubmed:authorpubmed-author:RoweAAlld:pubmed
pubmed-article:17300231pubmed:authorpubmed-author:McCannBBlld:pubmed
pubmed-article:17300231pubmed:authorpubmed-author:BunkerC BCBlld:pubmed
pubmed-article:17300231pubmed:authorpubmed-author:A'HernRRlld:pubmed
pubmed-article:17300231pubmed:authorpubmed-author:FearfieldL...lld:pubmed
pubmed-article:17300231pubmed:authorpubmed-author:LarkinJ M GJMlld:pubmed
pubmed-article:17300231pubmed:issnTypePrintlld:pubmed
pubmed-article:17300231pubmed:volume156lld:pubmed
pubmed-article:17300231pubmed:ownerNLMlld:pubmed
pubmed-article:17300231pubmed:authorsCompleteYlld:pubmed
pubmed-article:17300231pubmed:pagination440-7lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:meshHeadingpubmed-meshheading:17300231...lld:pubmed
pubmed-article:17300231pubmed:year2007lld:pubmed
pubmed-article:17300231pubmed:articleTitleExpression of p16, CD95, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma.lld:pubmed
pubmed-article:17300231pubmed:affiliationDepartment of Dermatology, Imperial College School of Medicine (START Laboratories), Chelsea and Westminster Hospital, London, UK. louise.fearfield@royalberkshire.nhs.uklld:pubmed
pubmed-article:17300231pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17300231pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17300231lld:pubmed